ConvaTec Group Plc

United Kingdom Country flag United Kingdom
Sector: Medical Supplies
Ticker: CTEC
ISIN: GB00BD3VFW73
Factsheet Factsheet

Market multiple valuation of ConvaTec Group Plc ( CTEC | GBR)

The most common multiple used in the valuation of stocks is the P/Earnings NTM multiple (Price to Earnings). P/E relates the current share price with the market expectations in terms of Earnings Per Share. This multiple is used to compare a company's market value with its earnings. A company with a high P/Earnings NTM is considered to be overvalued; a company with a low P/Earnings NTM is considered to be undervalued.
The P/Earnings NTM ratio of ConvaTec Group Plc is significantly higher than the median of its peer group: around 13.00. The company valuation of ConvaTec Group Plc according to these metrics is way above the market valuation of its peer group.
The P/Earnings NTM ratio of ConvaTec Group Plc is significantly higher than the average of its sector (Medical Supplies): 14.78. The company valuation of ConvaTec Group Plc according to these metrics is way above the market valuation of its sector.
The P/Earnings NTM ratio of ConvaTec Group Plc is lower than its historical 5-year average: 20.0. The (current) company valuation of ConvaTec Group Plc is therefore below its valuation average over the last five years.

Valuation
P/E Last P/E (e) 2025P/E NTM
ConvaTec Group PlcFree trialFree trialFree trial
International PeersFree trialFree trialFree trial
Medical Supplies10.1913.2214.78
Cboe UK 10019.7312.6912.33
United Kingdom4.5210.4710.43
More...
Beta (Ref: Cboe UK 100)
Levered betaUnlevered beta
1-Year0.380.34
2-Year0.460.41
3-Year0.580.51
More...
Stock Perf excl. Dividends (in GBP)
CTECCboe UK 100Rel. Perf.
Year-to-Date16.7%3.0%13.7%
1-Week1.3%1.9%-0.5%
1-Month-0.1%-2.3%2.2%
1-Year2.0%3.6%-1.7%
3-Year21.8%12.4%9.3%
5-Year27.9%38.0%-10.0%
More...
International Peers - ConvaTec Group Plc
Company NameCtryMarket
Cap.
last (mUSD)
ConvaTec Group PlcGBR-0.00
International Peers Median0.57
Advanced Medical Soluti...GBR-0.00
Outset Medical, Inc.USA600
Smith & Nephew plcGBR-0.00
Eiken Chemical Co., Ltd...JPN-0.00
Becton, Dickinson and C...USA59 670
GPRV Analysis
Created with Highcharts 4.1.70/102/104/106/108/1010/10
ConvaTec Group Plc
Intl. Peers
U.S Patents No. 7,882,001 & 8,082,201
More...
Net Sales Chart
Created with Highcharts 4.1.7Millions USD201920202021202220232024 (e)2025 (e)2026 (e)2027 (e)0k1k2k3k
More...
Quotes Chart

1-Year Rebased Stock Chart

  • ConvaTec Group Plc
  • Cboe UK 100
Created with Highcharts 4.1.7Jan '25May '24Sep '24May '25-20%-10%0%10%20%
More...

Did you know ?

Multiples charts provide an effective way to quickly analyze a company's valuation over a period of time, and compare it against the valuation of another company, a personal list, or a market index.

About Market Multiples

Many methods can be used to value a company. In reality, business valuation is often a combination of these different approaches. One of the most widely used quantitative methods is the market multiples method. The market valuation is utilized generally as a primary market input, to provide an objective starting point for the valuation. Put simply, this method multiplies the sales or profits of a business by an industry averaged multiplier to calculate the Market Value of the business.
Current multiples include:
- Historical multiples based on standardized financials for the last completed fiscal period: Last, Last Twelve Months (LTM);
- Forward multiples based on consensus estimates for the current fiscal period and next ones: Next Twelve Months (NTM), FY0, FY1.
Current multiples based on per-share metrics (such as earnings per share or book value per share) are calculated using the last closing price, while current multiples based on company-level metrics (such as net sales, EBIT or EBITDA) are calculated using the current market cap or EV (Enterprise Value).